Public Health and Consumer Groups respond to 2009 USTR Special 301 Report
Essential Action, AU Program on Information Justice and IP, Knowledge Ecology International, Forum on Democracy and Trade, Health GAP and Oxfam America
FOR IMMEDIATE RELEASE | April 30, 2009
Contact Info for each organization below with each quotation
WIPO’s five day 13th meeting of the Standing Committee on the Law of Patents (SCP) began on Monday, and will go through Friday. The agenda is quite full, as the SCP will consider four important reports written by the Secretariat.
SCP/13/2: Standards and Patents
SCP/13/3: Exclusions from Patentable Subject Matter and Exceptions and Limitations to the Rights
SCP/13/4: The Client-Attorney Privilege
SCP/13/5: Dissemination of Patent Information
The following discusses the 2009 PhRMA submission for the USTR Special 301 list on Thailand. Thailand is one of three Asian countries (China, Philippines and Thailand) that were singled out by PhRMA for the harshest treatment. The submission on Thailand covers several topics, including these:
One of the more aggressive PhRMA submissions to the USTR Special 301 list is the section on the Philippines. Excerpts, which are given below, illustrate the breath of PhRMA’s demands on the USTR. Continue Reading
On 3 March 2009, India delivered the following intervention at the WTO Council for TRIPS meeting on the issue of the public health dimension of the TRIPS Agreement in the context of the Dutch seizures.
_______________________________________________________________________
INTERVENTION by INDIA
Agenda item ‘M’ – OTHER BUSINESS – Public Health dimension of TRIPS Agreement
Chair,
As an early proponent of the use of patent pools to expand access to medical technologies, our initial reaction to the GSK announcement is that GSK is responding to several new developments.
February 19, 2009
Press Advisory on NGO letters to WHO and WTO on topic of Dutch seizures of generic medicines in-transit from India to Brazil, Colombia and Peru.
In response to news about four seizures of generic medicines manufactured in India and shipped through the Netherlands in route to Brazil, Colombia and Peru, sixteen public health, consumer and development NGOs have sent separate letters to the heads of the World Health Organization (WHO) and the World Trade Organization (WTO).
For more information, KEI general page on the Bayh Dole Act, or one of the mini Bayh-Dole timelines, such as the ones on transparency, march-in rights or royalty free uses. TIMELINE 1980 1980. October 21. Public Law 96-480. Stevenson-Wydler Technology… Continue Reading
On 3 February 2009 WIPO released the revised Report on the International Patent System (SCP/12/3 Rev.2) with three annexes. Continue Reading